GLP-1 Receptor Agonists: Have transformed the treatment options for type 2 diabetes and obesity
Animal data on LR3 infusion in pigs showed continued suppression of plasma growth hormone (~23% decrease) and IGFBP-3 across the 4-day infusion window (Tomas et al., 1997) by days 8-10 of a 10-day human community protocol, this kind of HPG-axis suppression would be expected to be active
Semaglutide remains valuable for patients who tolerate it well, patients with specific cost considerations, or patients who need a longer established safety record
It is not known if Ozempic when received through an injection passes into your breast milk Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas
While some people continue using GLP-1 for an extended period to maintain their weight loss, its not necessary to take it for life